Compass Therapeutics (CMPX) Amortizatization of Intangibles (2023 - 2026)
Compass Therapeutics' Amortizatization of Intangibles history spans 4 years, with the latest figure at $353000.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 57.59% to $353000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.3 million, a 22.8% increase, with the full-year FY2025 number at $1.2 million, up 2.75% from a year prior.
- Amortizatization of Intangibles hit $353000.0 in Q1 2026 for Compass Therapeutics, roughly flat from $353000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for CMPX hit a ceiling of $353000.0 in Q4 2025 and a floor of $219000.0 in Q4 2024.
- Historically, Amortizatization of Intangibles has averaged $300307.7 across 4 years, with a median of $307000.0 in 2023.
- Biggest five-year swings in Amortizatization of Intangibles: decreased 28.66% in 2024 and later surged 61.19% in 2025.
- Tracing CMPX's Amortizatization of Intangibles over 4 years: stood at $307000.0 in 2023, then decreased by 28.66% to $219000.0 in 2024, then surged by 61.19% to $353000.0 in 2025, then changed by 0.0% to $353000.0 in 2026.
- Business Quant data shows Amortizatization of Intangibles for CMPX at $353000.0 in Q1 2026, $353000.0 in Q4 2025, and $352000.0 in Q3 2025.